FDA Steps Up Actions for Misconduct in Drug and Device Development
(FDA: Rockville, Maryland) -- The U.S. Food and Drug Administration (FDA) recently announced it has stepped up its efforts to prevent noncompliant investigators and others from participating in new product development.